BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2907772)

  • 1. Amino groups in Clostridium perfringens epsilon prototoxin and epsilon toxin.
    Sakurai J; Nagahama M
    Microb Pathog; 1986 Oct; 1(5):417-23. PubMed ID: 2907772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides.
    Minami J; Katayama S; Matsushita O; Matsushita C; Okabe A
    Microbiol Immunol; 1997; 41(7):527-35. PubMed ID: 9272698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of one tryptophan residue in the lethal activity of Clostridium perfringens epsilon toxin.
    Sakurai J; Nagahama M
    Biochem Biophys Res Commun; 1985 Apr; 128(2):760-6. PubMed ID: 2859854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prior treatment with Clostridium perfringens epsilon toxin inactivated by various agents on lethal, pressor and contractile activities of the toxin.
    Nagahama M; Takahashi T; Sakurai J
    FEMS Microbiol Lett; 1990 Oct; 60(1-2):59-62. PubMed ID: 2283041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic processing and activation of Clostridium perfringens epsilon toxin by caprine small intestinal contents.
    Freedman JC; Li J; Uzal FA; McClane BA
    mBio; 2014 Oct; 5(5):e01994-14. PubMed ID: 25336460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical changes in the epsilon prototoxin molecule of Clostridium perfringens during enzymatic activation.
    Worthington RW; Mülders MS
    Infect Immun; 1977 Nov; 18(2):549-51. PubMed ID: 200566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of labeled Clostridium perfringens epsilon toxin in mice.
    Nagahama M; Sakurai J
    Toxicon; 1991; 29(2):211-7. PubMed ID: 2048139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential conformational environment of tryptophan in epsilon native prototoxin and active toxin from Clostridium perfringens type D.
    Kumar A; Kumar S; Sarma Dagger PV; Sharma Double Dagger AK
    J Biochem Mol Biol Biophys; 2002 Apr; 6(2):147-50. PubMed ID: 12186772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Clostridium perfringens epsilon toxin on the cardiovascular system of rats.
    Sakurai J; Nagahama M; Fujii Y
    Infect Immun; 1983 Dec; 42(3):1183-6. PubMed ID: 6315593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tryptophan content of Clostridium perfringens epsilon toxin.
    Sakurai J; Nagahama M
    Infect Immun; 1985 Jan; 47(1):260-3. PubMed ID: 2856914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of toxicity of Clostridium perfringens epsilon toxin.
    Bokori-Brown M; Savva CG; Fernandes da Costa SP; Naylor CE; Basak AK; Titball RW
    FEBS J; 2011 Dec; 278(23):4589-601. PubMed ID: 21518257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies on epsilon-prototoxin of Clostridium perfringens type D. Localization of the site of tryptic scission necessary for activation to epsilon-toxin.
    Bhown AS; Habeerb AF
    Biochem Biophys Res Commun; 1977 Oct; 78(3):889-96. PubMed ID: 199192
    [No Abstract]   [Full Text] [Related]  

  • 13. Enzymatic activation of Clostridium perfringens epsilon prototoxin and some biological properties of activated toxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):151-4. PubMed ID: 4369993
    [No Abstract]   [Full Text] [Related]  

  • 14. New insights into Clostridium perfringens epsilon toxin activation and action on the brain during enterotoxemia.
    Freedman JC; McClane BA; Uzal FA
    Anaerobe; 2016 Oct; 41():27-31. PubMed ID: 27321761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inactivation of Clostridium perfringens epsilon toxin by treatment with tetranitromethane and N-acetylimidazole.
    Sakurai J; Nagahama M
    Toxicon; 1987; 25(3):279-84. PubMed ID: 2884756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a lambda toxin-negative Clostridium perfringens strain that processes and activates epsilon prototoxin intracellularly.
    Harkness JM; Li J; McClane BA
    Anaerobe; 2012 Oct; 18(5):546-52. PubMed ID: 22982043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemical modification of epsilon-amino lysine groups in horseradish peroxidase. Its effect on catalytic properties and spatial structure of the enzyme].
    Ugarova NN; Rozhkova GD; Berezin IV
    Biokhimiia; 1978 Jul; 43(7):1242-50. PubMed ID: 29674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxyl groups in Clostridium perfringens epsilon toxin.
    Sakurai J; Nagahama M
    Microb Pathog; 1987 Dec; 3(6):469-74. PubMed ID: 2904641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational studies on modified proteins and peptides. VII. Conformation of epsilon-prototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity.
    Habeeb AF; Lee CL; Atassi MZ
    Biochim Biophys Acta; 1973 Oct; 322(2):245-50. PubMed ID: 4358084
    [No Abstract]   [Full Text] [Related]  

  • 20. Native or Proteolytically Activated NanI Sialidase Enhances the Binding and Cytotoxic Activity of Clostridium perfringens Enterotoxin and Beta Toxin.
    Theoret JR; Li J; Navarro MA; Garcia JP; Uzal FA; McClane BA
    Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29038129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.